Shares of ANGLE plc (LON:AGL – Get Free Report) crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 14.06 ($0.18) and traded as low as GBX 13.60 ($0.17). ANGLE shares last traded at GBX 14 ($0.18), with a volume of 659,855 shares.
Wall Street Analyst Weigh In
Separately, Berenberg Bank reiterated a “buy” rating and issued a GBX 70 ($0.88) target price on shares of ANGLE in a report on Wednesday, April 24th.
View Our Latest Research Report on AGL
ANGLE Stock Performance
About ANGLE
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.
See Also
- Five stocks we like better than ANGLE
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- AMD is Down 35%. Now is the Time to Buy the Dip
- Election Stocks: How Elections Affect the Stock Market
- Amazon Stands Tall: New Highs Are in Sight
- What Are Dividend Challengers?
- Chesapeake Energy Stock is The Energy Play, Earnings Confirm
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.